SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-23-175160
Filing Date
2023-06-26
Accepted
2023-06-26 16:26:58
Documents
1
Effectiveness Date
2023-06-26

Document Format Files

Seq Description Document Type Size
1 S-8 POS d461718ds8pos.htm S-8 POS 48437
  Complete submission text file 0001193125-23-175160.txt   49545
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-170044 | Film No.: 231042684
SIC: 2834 Pharmaceutical Preparations